Malaria is a serious but rare disease caused by bites from infected mosquitos. Now the drug is used to treat inflammatory diseases. Plaquenil and hyperpigmentation sjogren's Hydroxychloroquine alternative The American Academy of Ophthalmology AAO recently assembled a task force to examine the available evidence on these drugs and to develop screening recommendations that would be in accordance with both modern knowledge and the economic realities of practice Marmor MF, Carr RE, Easterbrook M, Farjo AA, Mieler WF, for the American Academy of. Background The American Academy of Ophthalmology recommendations on screening for chloroquine CQ and hydroxychloroquine HCQ retinopathy are revised in light of new information about the. A recent article published by the American Academy of Ophthalmology AAO presented new recommendations for screening of patients being managed with hydroxychloroquine HCQ. In this article, new recommendations were made that changed the previous monitoring paradigm. Some diseases treated with Plaquenil include: Plaquenil lowers your immune system’s ability to cause inflammation. This type of disease occurs when the body's immune system attacks its own healthy tissue. American academy of ophthalmology hydroxychloroquine screening Hydroxychloroquine retinopathy A review of imaging, New American Academy of Ophthalmology recommendations on. Hydroxychloroquine overdose side effectsBrand name for hydroxychloroquineSide effects of discontinuing plaquenil Hydroxychloroquine is a well-tolerated medication for various rheumatologic and dermatologic conditions. Its main side effects are gastrointestinal upset, skin rash, headache, and ocular toxicity1. Within the eye, hydroxychloroquine can adversely impact the cornea, ciliary body, and retina1 Hydroxychloroquine toxicity - EyeWiki - American Academy of Ophthalmology. My Take on New Ocular Screening Guidelines for Plaquenil.. Impact of the Revised American Academy of Ophthalmology.. Based on new data, the authors have revised the Academy’s 2011 guidelines to make screening recommendations more concise and practical. Ophthalmologists play a vital role in educating both patients and prescribing physicians about the risk of toxicity associated with exposure to hydroxychloroquine HCQ and chloroquine CQ drugs. Reused, with permission, from American Academy of Ophthalmology. Recommendations on Screening for Chloroquine and Hydroxychloroquine Retinopathy, Revised 2016. The Ophthalmic News and Education Network, American Academy of Ophthalmology. Mar 01, 2011 NEW SCREENING GUIDELINES. A task force of the American Academy of Ophthalmology published screening guidelines in 2002. However, new data indicate that the incidence of hydroxychloroquine toxicity may be higher than previously thought.